Treating Raynaud phenomenon: Beyond staying warm

Area of Science:

• Vascular Medicine
• Dermatology

Background:

• Raynaud phenomenon is characterized by exaggerated digital vascular responses to cold and stress.
• It presents as primary (idiopathic) or secondary to underlying conditions.
• Secondary Raynaud phenomenon carries a higher risk of severe ischemic complications, including digital ulceration and loss.

Purpose of the Study:

• To summarize the pathophysiology and management of Raynaud phenomenon.
• To highlight the potential for severe ischemic complications in secondary Raynaud phenomenon.
• To outline treatment strategies, including pharmacologic interventions.

Main Methods:

• Literature review of Raynaud phenomenon.
• Analysis of clinical presentations and complications.
• Overview of current therapeutic approaches.

Main Results:

• Raynaud phenomenon manifests as digital color changes and sensory symptoms.
• Ischemic complications are more prevalent and severe in secondary cases.
• Vasodilator agents are indicated when nonpharmacologic measures are insufficient.

Conclusions:

• Effective management of Raynaud phenomenon requires understanding its triggers and potential complications.
• Early recognition and treatment are crucial, especially for secondary Raynaud phenomenon.
• Pharmacologic therapy, particularly vasodilators, plays a key role in managing refractory cases.